menu

Medical Industry Feature: Urothelial Carcinoma: Case Study on a Patient Who Is Cisplatin Ineligible

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
BD

Urothelial Carcinoma: Case Study on a Patient Who Is Cisplatin Ineligible

Program Information
Recommended
Urothelial Carcinoma: Case Study on a Patient Who Is Cisplatin Ineligible
RestartResume
How do you evaluate your patients with urothelial carcinoma? How do you determine whether a patient is ineligible for cisplatin-based chemotherapy?
  • Sponsored by

  • Overview

    To demonstrate how he determines which of his urothelial carcinoma patients are ineligible for cisplatin-based chemotherapy, associate professor of medicine in the Department of Medicine at the University of Chicago Dr. Peter O’Donnell shares his expertise using a hypothetical patient case.

    US-OBD-00059 03/19

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 9/20/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.